- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03453125
Improving Learning in Hispanics With TBI or MS
December 23, 2021 updated by: Denise Krch, Kessler Foundation
Improving Learning in Hispanics With TBI or MS: A Pilot Trial
The goal of this study is to establish that a memory retraining protocol, originally developed for English-speakers, and translated into Spanish, is effective.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
A pilot study will be conducted to carry out this validation and resolve any methodological concerns in the translated protocol.
20 Spanish-speaking Hispanics at least one year post-traumatic brain injury (TBI) and 20 Spanish-speaking Hispanics with multiple sclerosis (MS), both with an objective deficit in learning and memory will be recruited.
Baseline assessment includes neuropsychological evaluation using traditional measures as well as completion of a number of questionnaires designed to measure everyday memory and everyday functioning.
Subjects are randomly assigned to either the experimental or control groups.
Experimental and control treatments includes two 45-60 minute sessions, twice per week, for 5 weeks.
Follow-up assessment includes a neuropsychological evaluation using traditional measures as well as completion of a number of questionnaires designed to measure everyday memory and everyday functioning.
Protocol efficacy will be determined by improvements between baseline and follow-up on an objective measure of learning and memory.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Arrasate-Mondragón, Spain
- Recruiting
- Hospital Aita Menni
-
Contact:
- Garazi Labayr Isusquiza, PhD
- Phone Number: +34 943794411
- Email: glabairu@aita-menni.org
-
Contact:
- Jose Ignacio, MD
- Phone Number: +34 943794411
- Email: jiquemada@aita-menni.org
-
-
-
-
New Jersey
-
East Hanover, New Jersey, United States, 07936
- Recruiting
- Kessler Foundation
-
Contact:
- Belinda Washington, BA
- Phone Number: 973-324-8440
- Email: bwashington@kesslerfoundation.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- between the ages of 18 and 65
- Spanish is my dominant language, and I have had a traumatic brain injury or I have multiple sclerosis.
Exclusion Criteria:
- Participants with major depressive disorder, schizophrenia, bipolar disorder I or II
- MS subjects: Individuals with a history of head injury, stroke, seizures, or any other significant neurological history will not be included in the study.
- TBI subjects: Individuals must have sustained a TBI at least one year prior to enrollment in the study protocol. Individuals with a history of significant neurological insult other than TBI (e.g. premorbid epilepsy, multiple sclerosis, Alzheimer's disease) will not be included in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Spanish mSMT Experimental Treatment
Administered by computer and paper and pencil.
|
|
|
Active Comparator: Spanish mSMT Control Treatment
Administered by computer and paper and pencil.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total learning post-treatment (covarying for baseline performance)
Time Frame: 7 weeks (between pre- and post testing)
|
Comparison between treatment and control groups on post-treatment Hopkins Verbal Learning Test (HVLT) learning score, covarying for baseline HVLT performance.
|
7 weeks (between pre- and post testing)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Nancy Chiaravalloti, PhD, Kessler Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 25, 2013
Primary Completion (Anticipated)
September 30, 2022
Study Completion (Anticipated)
September 30, 2022
Study Registration Dates
First Submitted
February 21, 2018
First Submitted That Met QC Criteria
February 26, 2018
First Posted (Actual)
March 5, 2018
Study Record Updates
Last Update Posted (Actual)
January 12, 2022
Last Update Submitted That Met QC Criteria
December 23, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Wounds and Injuries
- Craniocerebral Trauma
- Trauma, Nervous System
- Multiple Sclerosis
- Brain Injuries
- Brain Injuries, Traumatic
Other Study ID Numbers
- R-799-13
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on TBI (Traumatic Brain Injury) or MS (Multiple Sclerosis)
-
ElMindA LtdAthletico Physical TherapyCompletedMinor Traumatic Brain Injury (TBI)United States
-
Sheba Medical CenterRecruitingTraumatic Brain Injury (TBI) PatientsIsrael
-
ElMindA LtdNoran Neurological ClinicCompletedHealthy | Minor Traumatic Brain Injury (TBI)United States
-
Healing Hope InternationalNot yet recruitingTraumatic Brain Injury | Traumatic Brain Injury With Brief Loss of Consciousness | Traumatic Brain Injury (TBI); Concussion, Initial Encounter | Traumatic Brain Injury (TBI); Concussion, Subsequent Encounter | Traumatic Brain Injury (TBI) Patients | Traumatic Brain Injury With Persistent Cognitive...United States, Mexico
-
ElMindA LtdYork UniversityCompletedMinor Traumatic Brain Injury (TBI)Canada
-
Indiana UniversityNot yet recruitingTraumatic Brain Injury | TBI | Traumatic Brain Injury (TBI) PatientsUnited States
-
NHS Greater Glasgow and ClydeNot yet recruitingTraumatic Brain Injury (TBI); Concussion, Initial Encounter
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueRecruitingTBI (Traumatic Brain Injury)France
-
University of Texas Southwestern Medical CenterAlbert Einstein College of Medicine; National Institute of Neurological Disorders... and other collaboratorsRecruitingTBI (Traumatic Brain Injury) | TBI | Traumatic Brain Injury With Loss of Consciousness | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateUnited States
-
Mansoura UniversityRecruitingTBI Traumatic Brain InjuryEgypt
Clinical Trials on Spanish modified Story Memory Technique (mSMT)
-
Kessler FoundationNew Jersey Commission on Brain Injury ResearchCompleted
-
Kessler FoundationNational Multiple Sclerosis SocietyRecruitingMultiple SclerosisUnited States